Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Cassava Sciences stock | $8.04

Own Cassava Sciences stock in just a few minutes.

Fact checked

Cassava Sciences, Inc is a biotechnology business based in the US. Cassava Sciences shares (SAVA) are listed on the NASDAQ and all prices are listed in US Dollars. Cassava Sciences employs 9 staff and has a market cap (total outstanding shares value) of USD$234.7 million.

How to buy shares in Cassava Sciences

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Cassava Sciences. Find the stock by name or ticker symbol: SAVA. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Cassava Sciences reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$8.04, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Cassava Sciences, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Cassava Sciences. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Cassava Sciences share price

Use our graph to track the performance of SAVA stocks over time.

Cassava Sciences shares at a glance

Information last updated 2020-10-20.
Latest market closeUSD$8.04
52-week rangeUSD$1.1 - USD$12.68
50-day moving average USD$8.5289
200-day moving average USD$5.1548
Wall St. target priceUSD$17
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.274

Buy Cassava Sciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
$0 for US stocks
Stocks, Options, ETFs
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Cassava Sciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cassava Sciences price performance over time

Historical closes compared with the close of $8.04 from 2020-12-18

1 week (2021-01-07) -4.51%
1 month (2020-12-15) -0.12%
3 months (2020-10-15) -26.17%
6 months (2020-07-15) 137.17%
1 year (2020-01-15) -4.85%
2 years (2019-01-15) 637.61%
3 years (2018-01-13) N/A
5 years (2016-01-15) 384.34%

Cassava Sciences financials

Gross profit TTM USD$-1,568,000
Return on assets TTM -14.35%
Return on equity TTM -21.42%
Profit margin 0%
Book value $0.97
Market capitalisation USD$234.7 million

TTM: trailing 12 months

Shorting Cassava Sciences shares

There are currently 5.0 million Cassava Sciences shares held short by investors – that's known as Cassava Sciences's "short interest". This figure is 78.8% up from 2.8 million last month.

There are a few different ways that this level of interest in shorting Cassava Sciences shares can be evaluated.

Cassava Sciences's "short interest ratio" (SIR)

Cassava Sciences's "short interest ratio" (SIR) is the quantity of Cassava Sciences shares currently shorted divided by the average quantity of Cassava Sciences shares traded daily (recently around 17.8 million). Cassava Sciences's SIR currently stands at 0.28. In other words for every 100,000 Cassava Sciences shares traded daily on the market, roughly 280 shares are currently held short.

However Cassava Sciences's short interest can also be evaluated against the total number of Cassava Sciences shares, or, against the total number of tradable Cassava Sciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cassava Sciences's short interest could be expressed as 0.2% of the outstanding shares (for every 100,000 Cassava Sciences shares in existence, roughly 200 shares are currently held short) or 0.2156% of the tradable shares (for every 100,000 tradable Cassava Sciences shares, roughly 216 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Cassava Sciences.

Find out more about how you can short Cassava Sciences stock.

Cassava Sciences share dividends

We're not expecting Cassava Sciences to pay a dividend over the next 12 months.

Have Cassava Sciences's shares ever split?

Cassava Sciences's shares were split on a 1:7 basis on 10 May 2017. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cassava Sciences shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Cassava Sciences shares which in turn could have impacted Cassava Sciences's share price.

Cassava Sciences share price volatility

Over the last 12 months, Cassava Sciences's shares have ranged in value from as little as $1.1 up to $12.68. A popular way to gauge a stock's volatility is its "beta".

SAVA.US volatility(beta: 1.63)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cassava Sciences's is 1.6327. This would suggest that Cassava Sciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Cassava Sciences overview

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for nervous system disorders. Its lead therapeutic product candidate is PTI-125, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was founded in 1998 and is based in Austin, Texas.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site